All Posts

“Acquisition of new state-of-the-art assets for textile manufacturing, injection molding and 3D printing, implementation of robotics and digitalization in production processes, together with the expansion of the laboratory.”

On March 15, 2024, DIMA had the pleasure of hosting the fourth Expert Meeting on urinary incontinence and vaginal prolapse, endorsed by leading physicians from Germany and Spain. During this event, doctors had the opportunity to visit DIMA’s facilities, learn about how our products are manufactured, and attend presentations on the clinical experience of experts in the treatment of these conditions. In this edition, there were 15 participants, including gynecologists,   urogyn

Students from the Higher Vocational Training programs in Industrial Mechatronics and Administration and Finance visited our facilities as part of the new project “Professional Entrepreneurship Classroom” from IES Emilio Jimeno. This new initiative aims to enhance students’ entrepreneurial skills and competencies through the exchange of knowledge with local companies.

We have good news once again! We continue certifying DIMA products under the MDR regulation. This year, two products have obtained certification: one for male urinary incontinence (Male Remeex System) and another for vaginal prolapse (Surelift Anchorsure). What is the MDR? The Medical Device Regulation (EU) 2017/745 is the (relatively) new European regulation governing medical devices. It defines the requirements and obligations that all manufacturers and distributors must co

“New state-of-the-art assets to diversify production and services, improve environmental impact, and advance in digital transformation and Industry 4.0 technologies.”

DESARROLLO E INVESTIGACIÓN MÉDICA ARAGONESA S.L. has carried out a project for the installation of solar panels for self-consumption, contributing to the energy transition and the fight against climate change. The installation consists of 54 solar panels installed on the roof of the facility, with a total capacity of 24.30 kW, connected to a FRONIUS 25.0-3-S WLAN inverter, with an estimated annual production of 30,015 kWh. This project has been implemented within the incentiv

On October 18, 2023, DIMA had the pleasure of hosting the third Expert Meeting on urinary incontinence and vaginal prolapse, supported by leading physicians from Germany and Spain. During this event, physicians had the opportunity to visit DIMA’s facilities, learn about our manufacturing processes, and attend lectures where experts shared their experience in the treatment of these conditions.

"Acquisition of New Assets for the Diversification of Production and Process Automation. Development of a Sling for Urinary Incontinence."

We have great news to share! After years of hard work, we have successfully obtained MDR approval for two of our female urinary incontinence product families: Female Remeex System and Contasure Needleless. What is the MDR? The MDR is the new European Regulation on medical devices that defines the requirements and obligations that all manufacturers and distributors must comply with in order to market a medical device in the European market. In addition to incorporating the pre

The Investment Plan for Product Diversification carried out by DIMA, aimed at diversifying its portfolio of products related to the COVID-19 pandemic, has been co-financed through the grant programme for the manufacturing of medical supplies in response to the COVID-19 crisis, within the programme belonging to the Spanish Ministry of Industry, Trade and Tourism. Thanks to this support, DIMA has been able to carry out the necessary work at its facilities to expand and adapt t

DIMA is currently involved in several projects funded through a grant program for business projects aimed at Industrial Transformation and Development in Aragón , within the framework of the PAIP Aid Programme – TDI-ERDF Line. The grants requested by DIMA are generally focused on investment , industrial research , and experimental development . This funding helps us become more competitive in the medical sector.